Antimony potassium tartrate

Antimony potassium tartrate trihydrate

Ball-and-stick model of the bis(μ2-tartrato)-di-antimony anion,[1][2] [Sb2(C4H2O6)2]2−

  Carbon   Hydrogen

  Oxygen   Antimony
Names
Other names
potassium antimonyl tartrate
emetic tartar
tartar emetic
Identifiers
CAS Number
3D model (JSmol)
ChEBI
ChemSpider
ECHA InfoCard 100.116.333
Edit this at Wikidata
EC Number
  • 234-293-3
Gmelin Reference
 1332600
KEGG
PubChem CID
UNII
InChI
  • InChI=1S/2C4H4O6.2K.3H2O.2Sb/c2*5-1(3(7)8)2(6)4(9)10;;;;;;;/h2*1-2H,(H,7,8)(H,9,10);;;3*1H2;;/q2*-2;2*+1;;;;2*+3/p-4
    Key: WBTCZEPSIIFINA-UHFFFAOYSA-J
SMILES
  • [K+].[K+].O.O.O.O=C1O[Sb-]23OC1C1O[Sb-]4(OC(C(O2)C(=O)O3)C(=O)O4)OC1=O
Properties
Chemical formula
 K2Sb2(C4H2O6)2 · 3 H2O
Molar mass 667.87 g/mol
Appearance white crystalline powder
Density 2.6 g/cm3
Solubility in water
 8.3 g/100 mL (0 °C)
35.9 g/100 mL (100 °C)
Hazards
GHS labelling:
Pictograms
Signal word
 Warning
Lethal dose or concentration (LD, LC):
110 mg/kg
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Antimony potassium tartrate, also known as potassium antimonyl tartrate, potassium antimontarterate, or emetic tartar,[3] has the formula K2Sb2(C4H2O6)2. The compound has long been known as a powerful emetic, and was used in the treatment of schistosomiasis and leishmaniasis. It is used as a resolving agent. It typically is obtained as a hydrate.


Medical

The first treatment application against trypanosomiasis was tested in 1906, and the compound's use to treat other tropical diseases was researched.[4] The treatment of leishmania with antimony potassium tartrate started in 1913. After the introduction of antimony(V) containing complexes like sodium stibogluconate and meglumine antimoniate, the use of antimony potassium tartrate was phased out.[4][5] After British physician John Brian Christopherson's discovery in 1918 that antimony potassium tartrate could cure schistosomiasis, the antimonial drugs became widely used.[6][7][8] However, the injection of antimony potassium tartrate had severe side effects such as Adams–Stokes syndrome[9] and therefore alternative substances were under investigation. With the introduction and subsequent larger use of praziquantel in the 1970s, antimony-based treatments fell out of use.[10][11]

Tartar emetic was used in the late 19th and early 20th century in patent medicine as a remedy for alcohol intoxication, and was first ruled ineffective in the United States in 1941, in United States v. 11 1/4 Dozen Packages of Articles Labeled in Part Mrs. Moffat's Shoo-Fly Powders for Drunkenness.[12][13]

The New England Journal of Medicine reported[14] a case study of a patient whose wife secretly gave him a dose of a product called "tartaro emetico" which contained trivalent antimony (antimony potassium tartrate) and is sold in Central America as an aversive treatment for alcohol abuse. The patient, who had been out drinking the night before, developed persistent vomiting shortly after being given orange juice with the drug. When admitted to the hospital, and later in the intensive care unit, he experienced severe chest pains, cardiac abnormalities, renal and hepatic toxicity, and nearly died. The Journal reports that "Two years later, he [the patient] reports complete abstinence from alcohol."

Emetic

500 mg tartar emetic

Antimony potassium tartrate's potential as an emetic was known since the Middle Ages. The compound itself was considered toxic and therefore a different way to administer it was found. Cups made from pure antimony were used to store wine for 24 hours and then the resulting solution of antimony potassium tartrate in wine was consumed in small portions until the wanted emetic effect was reached.[15][16][17]

The compound is still used to induce vomiting in captured animals in order to study their diets.[18][19][20]

Preparation, structure, reactions

Antimony potassium tartrate is prepared by treating a solution of potassium hydrogen tartrate and antimony trioxide:

2 KOH + Sb2O3 + (HOCHCO2H)2 → K2Sb2(C4H2O6)2 + 3 H2O

With an excess of tartaric acid, the monoanionic monoantimony salt is produced:[21]

2 KOH + Sb2O3 + 4 (HOCHCO2H)2 → 2 KSb(C4H2O6)2 + 2 H2O

Antimony potassium tartrate has been the subject of several X-ray crystallography studies.[22][23][24][25][26][21] The core complex is an anionic dimer of antimony tartrate (Sb2(C4H2O6)22-) which is arraigned in a large ring with the carbonyl groups pointing outwards. The complex has D2 molecular symmetry with two Sb(III) centers bonded in distorted square pyramids. Water and potassium ions are held within the unit cell but are not tightly bound to the dimer. The anion is a well-used resolving agent.[27]

viewed along the x axis
viewed along the y axis
viewed along the z axis

Further reading

Of historic interest:

  • Frederick, George Mann (1952). Practical organic chemistry. England: Longmans, Green & Co. p. 115. ISBN 0582444071.
  • Knapp, Fr. (1839). "Zur Bildungsgeschichte des Brechweinsteins". Annalen der Pharmacie. 32: 76–85. doi:10.1002/jlac.18390320107.

References

  1. ↑ "CSD Entry: DKSBTR02 : Di-potassium bis(μ2-tartrato)-di-antimony trihydrate". Cambridge Structural Database: Access Structures. Cambridge Crystallographic Data Centre. doi:10.5517/cc89ghh. Retrieved 2021-12-06.
  2. ↑ Palenik, Ruth C.; Abboud, Khalil A.; Palenik, Gus J. (March 2005). "Bond valence sums and structural studies of antimony complexes containing Sb bonded only to O ligands". Inorganica Chimica Acta. 358 (4): 1034–1040. doi:10.1016/j.ica.2004.11.013.
  3. ↑ Sun, H.; Yan, S.C.; Cheng, W.S. (2003). "Interaction of antimony tartrate with the tripeptide glutathione". European Journal of Biochemistry. 267 (17): 5450–5457. doi:10.1046/j.1432-1327.2000.01605.x. PMID 10951203.
  4. 1 2 Low, George C. (1916). "The history of the use of intravenous injections of tartar emetic (Antimonium tartaratum) in tropical medicine". Transactions of the Royal Society of Tropical Medicine and Hygiene. 10 (2): 37–42. doi:10.1016/S0035-9203(16)90068-3.
  5. ↑ Navarro, Maribel; Gabbiani, Chiara; Messori, Luigi; Gambino, Dinorah (2010). "Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: Recent achievements and perspectives". Drug Discovery Today. 15 (23–24): 1070–8. doi:10.1016/j.drudis.2010.10.005. PMID 20974285.
  6. ↑ Christopherson, J.B. (1918). "The Successful Use of Antimony in Bilharziosis". The Lancet. 192 (4958): 325–327. doi:10.1016/S0140-6736(01)02807-0.
  7. ↑ Crichton-Harris, Ann (2009-07-15). Poison in small measure: Dr. Christopherson and the cure for bilharzia. ISBN 978-90-04-17541-9.
  8. ↑ Sabah, A.A.; Fletcher, Cathy; Webbe, G.; Doenhoff, M.J. (1986). "Schistosoma mansoni: Chemotherapy of infections of different ages". Experimental Parasitology. 61 (3): 294–303. doi:10.1016/0014-4894(86)90184-0. PMID 3086114.
  9. ↑ t'Ao, S. C. (1957). "Cardiac manifestations of the toxic action of potassium antimony tartrate in schistosomiasis patients: Paroxysmal ventricular tachycardia and fibrillation". Chinese Medical Journal. 75 (5): 365–378. PMID 13447130.
  10. ↑ Hagan, Paul (2009). "Schistosomiasis – a rich vein of research". Parasitology. 136 (12): 1611–9. doi:10.1017/S003118200999093X. PMID 19691867.
  11. ↑ Publishers, Bentham Science (October 1996). "The Antimonials". Current Medicinal Chemistry. pp. 304–305.
  12. ↑ Silverman, Matt (2003). Loony lawsuits. Barnes & Noble Books. p. 81. ISBN 9780760738931. Retrieved 1 January 2013.
  13. ↑ "United States v. 111/4 DOZEN PACKAGES, ETC..." Retrieved 1 January 2013.
  14. ↑ Macías Konstantopoulos, Wendy; Burns Ewald, Michele; Pratt, Daniel S. (2012). "Case 22-2012: A 34-Year-Old Man with Intractable Vomiting after Ingestion of an Unknown Substance". New England Journal of Medicine. 367 (3): 259–68. doi:10.1056/NEJMcpc1111580. PMID 22808962.
  15. ↑ McCallum, RI (1977). "President's address. Observations upon antimony". Proceedings of the Royal Society of Medicine. 70 (11): 756–63. doi:10.1177/003591577707001103. PMC 1543508. PMID 341167.
  16. ↑ Thomson, SC (1926). "Antimonyall Cupps: Pocula Emetica or Calices Vomitorii". Proceedings of the Royal Society of Medicine. 19 (Sect Hist Med): 122.2–128. doi:10.1177/003591572601901707. PMC 1948687. PMID 19985185.
  17. ↑ Weiss, S.; Hatcher, RA (1922). "The Mechanism of the Vomiting Induced by Antimony and Potassium Tartrate (Tartar Emetic)". Journal of Experimental Medicine. 37 (1): 97–111. doi:10.1084/jem.37.1.97. PMC 2128404. PMID 19868716.
  18. ↑ Poulin, B.; Lefebvre, G. t.; McNeil, R. (1994). "Effect and Efficiency of Tartar Emetic in Determining the Diet of Tropical Land Birds". The Condor. 96 (1): 98–104. doi:10.2307/1369067. JSTOR 1369067.
  19. ↑ Carlisle, J. D.; Holberton, R. L. (2006). "Relative Efficiency of Fecal versus Regurgitated Samples for Assessing Diet and the Deleterious Effects of a Tartar Emetic on Migratory Birds". Journal of Field Ornithology. 77 (2): 126–135. doi:10.1111/j.1557-9263.2006.00032.x. JSTOR 27639314.
  20. ↑ Diamond, Antony W.; Fayad, V. C.; McKinley, Peter S. (2007). "Commentary: Ipecac: An Improved Emetic for Wild Birds". Journal of Field Ornithology. 78 (4): 436–439. doi:10.1111/j.1557-9263.2007.00136.x. JSTOR 27715221.
  21. 1 2 Palenik, Ruth C.; Abboud, Khalil A.; Palenik, Gus J. (March 2005). "Bond valence sums and structural studies of antimony complexes containing Sb bonded only to O ligands". Inorganica Chimica Acta. 358 (4): 1034–1040. doi:10.1016/j.ica.2004.11.013.
  22. ↑ Grdenić, D.; Kamenar, B. (1 August 1965). "Structures involving unshared electron pairs: coordination of antimony in racemic potassium antimonyl tartrate". Acta Crystallographica. 19 (2): 197–199. doi:10.1107/S0365110X65003080.
  23. ↑ Banerjee, A.K.; Chari, K.V.R. (September 1969). "Structure of potassium antimony tartrate". Journal of Inorganic and Nuclear Chemistry. 31 (9): 2958–2962. doi:10.1016/0022-1902(69)80218-6.
  24. ↑ Iyer, R.Krishna; Deshpande, S.G.; Rao, G.S. (November 1972). "Studies on complexes of tartaric acid—I". Journal of Inorganic and Nuclear Chemistry. 34 (11): 3351–3356. doi:10.1016/0022-1902(72)80229-X.
  25. ↑ Kamenar, B.; Grdnić, D.; Prout, C. K. (31 March 1970). "The crystal and molecular structure of racemic potassium di-μ-tartrato-diantimonate(III) trihydrate (racemic `tartar emetic')". Acta Crystallographica Section B Structural Crystallography and Crystal Chemistry. 26 (3): 181–188. doi:10.1107/S0567740870002133.
  26. ↑ Gress, Mary E.; Jacobson, Robert A. (January 1974). "X-ray and white radiation neutron diffraction studies of optically active potassium antimony tartrate, K2Sb2(d-C4H2O6)2·3H2O (tarter emetic)". Inorganica Chimica Acta. 8: 209–217. doi:10.1016/S0020-1693(00)92617-3.
  27. ↑ F. P. Dwyer, F. L. Garvan (1960). "Resolution of cis‐Dinitrobis(ethylenediamine)cobalt Ion". Inorganic Syntheses. 6: 195-197. doi:10.1002/9780470132371.ch62.{{cite journal}}: CS1 maint: uses authors parameter (link)

Further reading

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.